Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Ubiome Gut EXPLORER
10% OFF

Update : discount is suspended
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

London TMAU meeting with Prof Liz Shephard
19th Oct 11am - 1pm
St Mary's Hospital
Praed St, Paddington
London W2 1NY
click to read more

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Tuesday, March 29, 2011

MEBO-Eliapharma TMAU Testing Update and next batch of tests

Even as we wait for the results of the 38 specimen of the 1st batch analyzed by Eliapharma, we already have an additional 12 samples for the next batch.
At this time, Eliapharma is writing the reports of the first 38 samples received for TMAU Testing for Primary TMAU, Secondary TMAU, or negative results.

Urine Creatinine Test: In addition to TMAU testing, Eliapharma is analyzing each sample to measure urine creatinine concentration levels to act as the reference point for measuring TMA and TMAO. This is something also done by Nigel Manning in the UK, as noted in his paper, TMAU - diagnostic testing at Sheffield Children's Hospital, which Nigel wrote for MEBO's Meetup in Nashville 2010.

A urine creatinine concentration level test can be done on its own or with other tests that determine the relative amounts of other substances being excreted in the urine. High creatinine levels indicate a pure test, whereas low amounts of creatinine in the urine indicate an altered test perhaps by drinking excessive amounts of water or taking medication containing diuretics. This additional measure to test the creatinine concentration in each specimen serves to ensure that the urine samples are of good quality. Normally, this test is done as a screening test to evaluate kidney function, but also to provide information on other chemicals in the urine such as albumin or protein.


Even as we wait for the results of the 38 specimen of the 1st batch analyzed by Eliapharma, we already have an additional 12 samples for the next batch. In addition, so far 5 people have expressed interest in providing a sample during the Washington DC Meetup on the weekend of the 9th and 10th of April, and others might decide to do the test as well once they’re at the meetup. So, by mid April, we should have close to 20 samples, and hopefully complete the 30 required to run the test by early May. As per our agreement with Eliapharma, the lab will analyze approximately 30 samples at a time.


If you would like to test in our MEBO International TMAU Testing Program, please fill the test following, MEBO-Eliapharma TMAU Test Requisition/Survey Form.

We are looking forward to receiving the results of this first batch of 38 samples sometime this week.

María

María de la Torre
President and Executive Director



0 comments:

Post a Comment